Claire J. Moore

North Terrace
Adelaide, SA 5000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Journal: Pharmacogenomics

Published: July 06, 2026

Implementing Pharmacogenomics in Contemporary Hospital Care: Insights from Multidisciplinary Knowledge Exchange.

Implementing Pharmacogenomics in Contemporary Hospital Care: Insights from Multidisciplinary Knowledge Exchange.

Journal: Pharmacogenomics and personalized medicine

Published: March 08, 2026

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.

Journal: Clinical pharmacology and therapeutics

Published: January 13, 2026

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Journal: Pediatric transplantation

Published: November 03, 2025

Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectives.

Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectives.

Journal: Genetics in medicine open

Published: May 14, 2025

Real-World Applications of Pharmacogenomics in Paediatrics.

Real-World Applications of Pharmacogenomics in Paediatrics.

Journal: Journal of paediatrics and child health

Published: April 29, 2025

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.

Journal: Clinical and translational science

Published: February 17, 2025

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.

Journal: Clinical and translational science

Published: December 22, 2024

CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysis.

CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysis.

Journal: Clinical and translational science

Published: October 07, 2024

Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.

Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.

Journal: Clinical pharmacology and therapeutics

Published: July 08, 2024

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation.

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation.

Journal: BMJ open

Published: May 17, 2024

Benchmarking pharmacogenomics genotyping tools: Performance analysis on short-read sequencing samples and depth-dependent evaluation.

Benchmarking pharmacogenomics genotyping tools: Performance analysis on short-read sequencing samples and depth-dependent evaluation.

Journal: Clinical and translational science

Published: May 16, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026